Investor desk
Investors should track partnership announcements and pipeline signals from ESMO.
Meet the Scientific Co-Chairs of the ESMO Congress 2026 - OncoDaily July 2026 OncoDaily IO OncoDaily GI Hemostasis Today Fertility News Mar 11, 2026 1:55 am Mar 14, 2026 1:45 pm # Meet the Scientific Co-Chairs of the ESMO Congress 2026 The European Society for Medical Oncol
Presentation data updated Jul 22, 2026, 2:31 AM UTC
Meet the Scientific Co-Chairs of the ESMO Congress 2026 - OncoDaily July 2026 OncoDaily IO OncoDaily GI Hemostasis Today Fertility News Mar 11, 2026 1:55 am Mar 14, 2026 1:45 pm # Meet the Scientific Co-Chairs of the ESMO Congress 2026 The European Society for Medical Oncology (ESMO) will host the ESMO Congress 2026 from 23–27 October 2026 in Madrid, Spain, bringing together leading oncology
Meet the Scientific Co-Chairs of the ESMO Congress 2026 - OncoDaily July 2026 OncoDaily IO OncoDaily GI Hemostasis Today Fertility News Mar 11, 2026 1:55 am Mar 14, 2026 1:45 pm # Meet the Scientific Co-Chairs of the ESMO Congress 2026 The European Society for Medical Oncology (ESMO) will host the ESMO Congress 2.
Expect signals on pricing, formulary strategy, and partnership economics in EU markets.
EMA and national HTA frameworks are frequently debated at industry gatherings.
Investors should track partnership announcements and pipeline signals from ESMO.
Competitive positioning among oncology players is a core theme — compare with prior editions.
Tier-1 industry catalyst
ESMO is a targeted oncology forum where specialty pipeline readouts and BD conversations drive near-term positioning decisions. Primary driver: speaker calibre and KOL density.
Plenary and late-breaker slots attract global KOLs — high signal for clinical and regulatory teams.
Smaller exhibitor set — focus on disclosed presenters rather than floor traffic.
Some historical catalysts; compare readouts against last cycle.
Niche coverage — subscribe for direct abstract alerts.
Early science or services-focused — lower near-term PDUFA linkage.
Abstract discovery in progress; monitor Key Data tab.
Live readouts, late-breakers, and partnership announcements.
Nova editorial monitors confirmed data releases.
Post-event recap, competitive takeaways, and trial updates.
Meet the Scientific Co-Chairs of the ESMO Congress 2026 - OncoDaily July 2026 OncoDaily IO OncoDaily GI Hemostasis Today Fertility News Mar 11, 2026 1:55 am Mar 14, 2026 1:45 pm # Meet the Scientific Co-Chairs of the ESMO Congress 2026 The European Society for Medical Oncology (ESMO) will host the ESMO Congress 2
Primary audience: BD teams · Investors & analysts · Regulatory leaders
Investors should track partnership announcements and pipeline signals from ESMO.
EMA and national HTA frameworks are frequently debated at industry gatherings.
Competitive positioning among oncology players is a core theme — compare with prior editions.
| Edition | Presentations | Companies |
|---|---|---|
| ESMO (current) | 0 | 0 |
| ESMO Gastrointestinal Cancers Congress (2026) | 1 | 0 |
| ESMO Preceptorship on Neuroendocrine (2026) | 0 | 0 |
Competitive positioning among oncology players is a core theme — compare with prior editions.
No coverage articles yet. Check back closer to the event.
Standalone summaries for ESMO — optimized for research and AI retrieval.
Meet the Scientific Co-Chairs of the ESMO Congress 2026 - OncoDaily July 2026 OncoDaily IO OncoDaily GI Hemostasis Today Fertility News Mar 11, 2026 1:55 am Mar 14, 2026 1:45 pm # Meet the Scientific Co-Chairs of the ESMO Congress 2026 The European Society for Medical Oncology (ESMO) will host the ESMO Congress 2
Meet the Scientific Co-Chairs of the ESMO Congress 2026 - OncoDaily July 2026 OncoDaily IO OncoDaily GI Hemostasis Today Fertility News Mar 11, 2026 1:55 am Mar 14, 2026 1:45 pm # Meet the Scientific Co-Chairs of the ESMO Congress 2026 The European Society for Medical Oncology (ESMO) will host the ESMO Congress 2
Investors should track partnership announcements and pipeline signals from ESMO.
BD teams should prioritize partnership and licensing conversations at ESMO.
AI-assisted answers grounded in NovaPharmaNews intelligence
Answers use retrieved site intelligence plus AI synthesis. Verify critical decisions with primary sources.
ESMO is a oncology industry conference for executives, clinical leaders, and investors.
Typical attendees include pharma executives, BD teams, investors, and regulatory professionals focused on oncology.
ESMO influences partnership timing and policy debates affecting oncology markets for the next 12–18 months.
ESMO is held in Madrid, Spain.
Track partnership announcements, pipeline readouts, and management commentary on oncology catalysts.
BD teams use ESMO for licensing, co-development, and vendor selection across oncology.
ESMO is a tier-1 global congress for oncology — compare with peer events in the same vertical.
Subscribe to event alerts on this page for pre-event briefs, live coverage, and post-event analysis.